Cargando…
Rational design of a protein that binds integrin α(v)β(3) outside the ligand binding site
Integrin α(v)β(3) expression is altered in various diseases and has been proposed as a drug target. Here we use a rational design approach to develop a therapeutic protein, which we call ProAgio, that binds to integrin α(v)β(3) outside the classical ligand-binding site. We show ProAgio induces apopt...
Autores principales: | Turaga, Ravi Chakra, Yin, Lu, Yang, Jenny J., Lee, Hsiauwei, Ivanov, Ivaylo, Yan, Chunli, Yang, Hua, Grossniklaus, Hans E., Wang, Siming, Ma, Cheng, Sun, Li, Liu, Zhi-Ren |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4895024/ https://www.ncbi.nlm.nih.gov/pubmed/27241473 http://dx.doi.org/10.1038/ncomms11675 |
Ejemplares similares
-
Targeting integrin αvβ3 by a rationally designed protein for chronic liver disease treatment
por: Turaga, Ravi Chakra, et al.
Publicado: (2021) -
Modulation of Cancer-Associated Fibrotic Stroma by An Integrin α(v)β(3) Targeting Protein for Pancreatic Cancer Treatment
por: Turaga, Ravi Chakra, et al.
Publicado: (2020) -
Kindlin-2 directly binds actin and regulates integrin outside-in signaling
por: Bledzka, Kamila, et al.
Publicado: (2016) -
Unraveling determinants of transcription factor binding outside the core binding site
por: Levo, Michal, et al.
Publicado: (2015) -
β-Subunit Binding Is Sufficient for Ligands to Open the Integrin α(IIb)β(3) Headpiece
por: Lin, Fu-Yang, et al.
Publicado: (2016)